Gap Debate: CRISPR for Neurodegeneration

completed | neurodegeneration | 2026-04-03

Knowledge Graph: 80 edges — View JSON

Hypotheses (7)

#1 Prime Editing Precision Correction of APOE4 to APOE3 in Microglia

0.743

APOE

Utilize optimized prime editing systems with microglia-targeted AAV delivery to convert the disease-associated APOE4 C130R mutation to protective APOE3 variant. This approach targets the primary cell

#2 Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mismatch Repair Modulation

0.623

MSH3, PMS1

Deploy CRISPR interference (CRISPRi) to selectively downregulate MSH3 and PMS1 expression specifically during neuronal maturation phases, creating temporal windows of CAG repeat stability in Huntingto

#3 Multiplexed Base Editing for Simultaneous Neuroprotective Gene Activation

0.611

SOD1, TARDBP, BDNF, GDNF, IGF-1

Engineer multiplexed cytosine base editors coupled with CRISPRa to simultaneously correct disease-causing mutations while upregulating endogenous neuroprotective factors (BDNF, GDNF, IGF-1) in the sam

#4 Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromatin Remodeling

0.583

SIRT1, FOXO3, NRF2, TFAM

## Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromatin Remodeling ### Mechanistic Hypothesis Overview This hypothesis proposes a disease-modifying strategy centered on **Epigenetic Memory

#5 CRISPR-Mediated Mitochondrial Genome Editing for Complex I Dysfunction

0.570

MT-ND1, MT-ND4, MT-ND6

## CRISPR-Mediated Mitochondrial Genome Editing for Complex I Dysfunction ### Mechanistic Hypothesis Overview This hypothesis proposes a disease-modifying strategy centered on **CRISPR-Mediated Mito

#6 Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention for Severe Neurodevelopmental Forms

0.540

SOD1, HTT, TARDBP

Deploy acid-degradable lipid nanoparticles (ADP-LNPs) for in utero intracerebroventricular delivery of base editors to correct dominant mutations in severe early-onset neurodegenerative diseases.

#7 Conditional CRISPR Kill Switches for Aberrant Protein Clearance

0.484

UBE3A, PARK2, PINK1

Engineer inducible CRISPR systems that activate only in the presence of misfolded protein aggregates, triggering targeted degradation pathways or selective elimination of severely affected neurons.